ATE199545T1 - Inhibitoren retroviraler proteasen - Google Patents
Inhibitoren retroviraler proteasenInfo
- Publication number
- ATE199545T1 ATE199545T1 AT93911046T AT93911046T ATE199545T1 AT E199545 T1 ATE199545 T1 AT E199545T1 AT 93911046 T AT93911046 T AT 93911046T AT 93911046 T AT93911046 T AT 93911046T AT E199545 T1 ATE199545 T1 AT E199545T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- retroviral proteases
- chem
- retroviral
- proteases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88670092A | 1992-05-21 | 1992-05-21 | |
PCT/US1993/004208 WO1993023379A1 (en) | 1992-05-21 | 1993-05-04 | Retroviral protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE199545T1 true ATE199545T1 (de) | 2001-03-15 |
Family
ID=25389564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93911046T ATE199545T1 (de) | 1992-05-21 | 1993-05-04 | Inhibitoren retroviraler proteasen |
Country Status (11)
Country | Link |
---|---|
US (10) | US5648364A (de) |
EP (4) | EP0957093A3 (de) |
JP (1) | JPH07508020A (de) |
AT (1) | ATE199545T1 (de) |
AU (1) | AU667376B2 (de) |
CA (1) | CA2136312A1 (de) |
DE (1) | DE69329996T2 (de) |
DK (1) | DK0641325T3 (de) |
ES (1) | ES2155069T3 (de) |
GR (1) | GR3035526T3 (de) |
WO (1) | WO1993023379A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
EP0565631B1 (de) * | 1991-01-02 | 1996-09-18 | Merrell Pharmaceuticals Inc. | Antivirale verbindungen |
EP0957093A3 (de) | 1992-05-21 | 2000-04-12 | Monsanto Company | Retrovirusprotease Inhibitoren |
US5783701A (en) | 1992-09-08 | 1998-07-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
US5846993A (en) * | 1992-12-22 | 1998-12-08 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
CA2166693C (en) * | 1993-07-08 | 1999-08-24 | Daniel Schirlin | Difluoro statone analogs |
HUT74569A (en) * | 1993-09-09 | 1997-01-28 | Merrell Pharma Inc | Difluoro statone antiviral analogs, pharmaceutical compn. contg. them and process for preparing the said comds. |
US5587514A (en) * | 1993-11-08 | 1996-12-24 | Emory University | Diastereoselective synthesis of hydroxyethylene dipeptide isosteres |
WO1995024385A1 (en) * | 1994-03-07 | 1995-09-14 | Vertex Pharmaceuticals Incorporated | Sulphonamide derivatives as aspartyl protease inhibitors |
US5527829A (en) * | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
EP0804428B1 (de) | 1995-01-20 | 2007-12-26 | G.D. Searle LLC. | Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen |
US5691372A (en) * | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
US6004957A (en) * | 1995-06-07 | 1999-12-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
US6114380A (en) * | 1995-12-18 | 2000-09-05 | Merrell Pharmaceuticals Inc. | Difluoro statone analogs |
US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
US5925759A (en) | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
DE19703713A1 (de) * | 1997-01-23 | 1998-07-30 | Hans Prof Dr Schick | Verfahren für die Herstellung von Oxetan-2-onen und Zwischenprodukte |
US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
US6084107A (en) * | 1997-09-05 | 2000-07-04 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
ATE285396T1 (de) | 1998-06-19 | 2005-01-15 | Vertex Pharma | Sulfonamide als aspartyl-protease-inhibitoren |
US6538006B1 (en) | 1998-07-08 | 2003-03-25 | Pharmacia Corporation | Retroviral protease inhibitors |
WO2000006035A1 (en) * | 1998-07-31 | 2000-02-10 | Surx, Inc. | Limited heat transfer devices and methods to shrink tissues |
KR100277723B1 (ko) * | 1998-12-14 | 2001-01-15 | 남창우 | 광학적으로 순수한 데카하이드로이소퀴놀린카르복사미드의 연속제조공정 |
CZ299699B6 (cs) * | 1998-12-14 | 2008-10-22 | Sk Corporation | Zpusob výroby [3S-(3alfa, 4alfabeta, 8alfabeta)]-N-terc-butyl-dekahydro-3-izochinolinkarboxamidu s vysokým optickým výtežkem |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA9334A (en) * | 1878-11-11 | Josiah M. Simpson | Improvements in boiler feeders | |
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
EP0068378B1 (de) * | 1981-06-26 | 1986-03-05 | Schering Corporation | Imidazo(1,2-a)pyridine und -pyrazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
DE3377497D1 (en) * | 1982-09-15 | 1988-09-01 | Haessle Ab | Enzyme inhibitors |
EP0114993B1 (de) * | 1982-12-27 | 1990-05-16 | Merck & Co. Inc. | Reninhemmende Tripeptide |
US4668770A (en) * | 1982-12-27 | 1987-05-26 | Merck & Co., Inc. | Renin inhibitory tripeptides |
EP0118223A1 (de) * | 1983-02-07 | 1984-09-12 | Aktiebolaget Hässle | Enzymhemmende Stoffe |
JPS59227851A (ja) * | 1983-06-09 | 1984-12-21 | Sankyo Co Ltd | レニン阻害作用を有するペプチド類 |
US4514391A (en) * | 1983-07-21 | 1985-04-30 | E. R. Squibb & Sons, Inc. | Hydroxy substituted peptide compounds |
US4477441A (en) * | 1983-09-14 | 1984-10-16 | Merck & Co., Inc. | Renin inhibitors containing a C-terminal disulfide cycle |
US4645759A (en) * | 1984-06-22 | 1987-02-24 | Abbott Laboratories | Renin inhibiting compounds |
JPS6173237A (ja) * | 1984-09-18 | 1986-04-15 | Hitachi Maxell Ltd | 磁気デイスク |
US4616088A (en) * | 1984-10-29 | 1986-10-07 | E. R. Squibb & Sons, Inc. | Amino acid ester and amide renin inhibitor |
US4688770A (en) * | 1985-06-10 | 1987-08-25 | V-K Enterprises, Inc. | Guide assembly for cutting torch tip |
US4668769A (en) * | 1985-08-02 | 1987-05-26 | Hoover Dennis J | Oxa- and azahomocyclostatine polypeptides |
US4599198A (en) * | 1985-08-02 | 1986-07-08 | Pfizer Inc. | Intermediates in polypeptide synthesis |
CA1282549C (en) * | 1985-11-12 | 1991-04-02 | Eric M. Gordon | Aminocarbonyl renin inhibitors |
CA1297631C (en) * | 1985-12-23 | 1992-03-17 | Sesha I. Natarajan | Ureido renin inhibitors |
US4757050A (en) * | 1985-12-23 | 1988-07-12 | E. R. Squibb Sons, Inc. | Ureido renin inhibitors |
US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
DE3635907A1 (de) * | 1986-10-22 | 1988-04-28 | Merck Patent Gmbh | Hydroxy-aminosaeurederivate |
CH676988A5 (de) * | 1987-01-21 | 1991-03-28 | Sandoz Ag | |
USH725H (en) * | 1987-02-26 | 1990-01-02 | E. R. Squibb & Sons, Inc. | Ureido amino and imino acids, compositions and methods for use |
GB8707412D0 (en) * | 1987-03-27 | 1987-04-29 | Fujisawa Pharmaceutical Co | Peptide compounds |
DE3830825A1 (de) * | 1987-09-15 | 1989-03-23 | Sandoz Ag | Hydrophile reninhemmer, ihre herstellung und verwendung |
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
US4977277A (en) * | 1988-05-09 | 1990-12-11 | Abbott Laboratories | Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof |
IL90218A0 (en) * | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
JP2512787B2 (ja) * | 1988-07-29 | 1996-07-03 | 株式会社日立製作所 | 内燃機関のスロットル開度制御装置 |
IL91307A0 (en) * | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
CA2012306A1 (en) * | 1989-03-28 | 1990-09-28 | Werner Neidhart | Amino acid derivatives |
JP2701932B2 (ja) * | 1989-04-10 | 1998-01-21 | サントリー株式会社 | タンパク質分解酵素阻害剤 |
DE3912829A1 (de) * | 1989-04-19 | 1990-10-25 | Bayer Ag | Verwendung von renininhibitorischen peptiden als mittel gegen retroviren |
WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
WO1992000750A1 (en) | 1990-07-06 | 1992-01-23 | Smithkline Beecham Corporation | Retroviral protease inhibitors |
EP0472077A3 (en) * | 1990-08-24 | 1993-03-31 | Bayer Ag | Phosphonate containing hydroxyethylamin- and norstatin-type pseudopeptides |
CA2052902A1 (en) * | 1990-10-11 | 1992-04-12 | Laszlo R. Treiber | Inhibitor of hiv protease |
CA2052907A1 (en) * | 1990-10-11 | 1992-04-12 | Joseph P. Vacca | Hiv protease inhibitors having symmetrical structure |
EP0480624A1 (de) * | 1990-10-11 | 1992-04-15 | Merck & Co. Inc. | HIV Protease Hemmstoffe |
JPH06505963A (ja) * | 1990-11-19 | 1994-07-07 | モンサント カンパニー | レトロウイルスプロテアーゼ阻害剤 |
EP0957093A3 (de) * | 1992-05-21 | 2000-04-12 | Monsanto Company | Retrovirusprotease Inhibitoren |
US5780455A (en) * | 1994-08-24 | 1998-07-14 | Merck & Co., Inc. | Intravenous alendronate formulations |
US5646364A (en) * | 1995-06-19 | 1997-07-08 | Donald Lee Chastain | Explosive device for use in underwater demolition operations and method therefor |
-
1993
- 1993-05-04 EP EP99113622A patent/EP0957093A3/de not_active Ceased
- 1993-05-04 WO PCT/US1993/004208 patent/WO1993023379A1/en active IP Right Grant
- 1993-05-04 DE DE69329996T patent/DE69329996T2/de not_active Expired - Fee Related
- 1993-05-04 EP EP93911046A patent/EP0641325B1/de not_active Expired - Lifetime
- 1993-05-04 CA CA002136312A patent/CA2136312A1/en not_active Abandoned
- 1993-05-04 EP EP04005829A patent/EP1447398A1/de not_active Withdrawn
- 1993-05-04 JP JP6503622A patent/JPH07508020A/ja active Pending
- 1993-05-04 DK DK93911046T patent/DK0641325T3/da active
- 1993-05-04 ES ES93911046T patent/ES2155069T3/es not_active Expired - Lifetime
- 1993-05-04 AT AT93911046T patent/ATE199545T1/de not_active IP Right Cessation
- 1993-05-04 AU AU42327/93A patent/AU667376B2/en not_active Expired - Fee Related
- 1993-05-04 EP EP01118721A patent/EP1148050A1/de not_active Withdrawn
-
1995
- 1995-03-21 US US08/408,166 patent/US5648364A/en not_active Expired - Fee Related
- 1995-05-31 US US08/455,237 patent/US5643924A/en not_active Expired - Fee Related
- 1995-05-31 US US08/454,788 patent/US5756534A/en not_active Expired - Fee Related
-
1997
- 1997-04-08 US US08/835,528 patent/US5948790A/en not_active Expired - Fee Related
-
1998
- 1998-08-26 US US09/140,922 patent/US6180646B1/en not_active Expired - Fee Related
-
2000
- 2000-10-31 US US09/699,515 patent/US6506759B1/en not_active Expired - Fee Related
-
2001
- 2001-03-08 GR GR20010400319T patent/GR3035526T3/el not_active IP Right Cessation
-
2002
- 2002-09-18 US US10/245,710 patent/US6762187B2/en not_active Expired - Fee Related
-
2004
- 2004-03-05 US US10/793,672 patent/US7026485B2/en not_active Expired - Fee Related
-
2006
- 2006-01-13 US US11/331,344 patent/US7312333B2/en not_active Expired - Fee Related
-
2007
- 2007-12-11 US US12/000,244 patent/US20080103311A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030195227A1 (en) | 2003-10-16 |
US20050004230A1 (en) | 2005-01-06 |
CA2136312A1 (en) | 1993-11-25 |
GR3035526T3 (en) | 2001-06-29 |
EP0957093A2 (de) | 1999-11-17 |
US20080103311A1 (en) | 2008-05-01 |
DE69329996D1 (de) | 2001-04-12 |
WO1993023379A1 (en) | 1993-11-25 |
DE69329996T2 (de) | 2001-09-06 |
ES2155069T3 (es) | 2001-05-01 |
US5643924A (en) | 1997-07-01 |
US5648364A (en) | 1997-07-15 |
US6762187B2 (en) | 2004-07-13 |
US7312333B2 (en) | 2007-12-25 |
EP1447398A1 (de) | 2004-08-18 |
US6506759B1 (en) | 2003-01-14 |
EP0641325A1 (de) | 1995-03-08 |
US6180646B1 (en) | 2001-01-30 |
US5756534A (en) | 1998-05-26 |
AU4232793A (en) | 1993-12-13 |
EP1148050A1 (de) | 2001-10-24 |
EP0641325B1 (de) | 2001-03-07 |
JPH07508020A (ja) | 1995-09-07 |
US20060166895A1 (en) | 2006-07-27 |
EP0957093A3 (de) | 2000-04-12 |
AU667376B2 (en) | 1996-03-21 |
US5948790A (en) | 1999-09-07 |
US7026485B2 (en) | 2006-04-11 |
DK0641325T3 (da) | 2001-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69329996D1 (de) | Inhibitoren retroviraler proteasen | |
DE69132435D1 (de) | Inhibitoren retroviraler Proteasen | |
NO954427D0 (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
FI944217A (fi) | Substituoidut pipekoliinihappojohdannaiset HIV-proteaasin estäjinä | |
NO180718C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater | |
ATE382041T1 (de) | Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen | |
FI932249A0 (fi) | Dubbelverkande inhibitorer | |
DK0776324T3 (da) | Endothelin-antagonister | |
ATE143262T1 (de) | Inhibitoren der retroviralen protease | |
DE69526330D1 (de) | Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxids | |
KR950700323A (ko) | 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE) | |
FI931855A0 (fi) | Farmaceutisk sammansaettning som innehaoller kinolin- och kinazolinderivat samt nya foereningar daerfoer | |
SE9100920D0 (sv) | New active compounds | |
FI935644A (fi) | Retrovirusten proteaasi-inhibiittoreita | |
FI962073A0 (fi) | HIV-proteaasin estäjän prodrug-muotoja | |
NO934721D0 (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |